The Image Computing, Analysis and Repository Facility, or ICAR (an expansion of the former Scientific Image Reconstruction and Analysis Facility or SIRAF) provides computing infrastructure, image analysis software, expert consultation, image-archiving and image analysis services to researchers across the University of Chicago Comprehensive Cancer Center (UCCCC). The Core's computing facilities include a cluster with nearly 300 CPU cores and 48 TB of data storage, used for high-intensity computation associated with image reconstruction, analysis and visualization. The intention of this Facility is to provide capability far above that available from an individual investigator?s workstation, while also allowing interactive respon,3e and quick turnaround, features lacking from larger scale facilities such as the Beagle high performance computer in the University's Computation Institute. The Core's computing facilities are heavily used by translational researchers in development of imaging techniques for cancer diagnosis, treatment and assessment. The image analysis mission of the ICAR Facility is to allow researchers, whose focus is not imaging per se, but cancer-related, to take maximum advantage of the available imaging modalities - supplying expertise in image analysis at whatever level is required - whether simple consultation and recommendation, shared development of new analysis software for use by researchers who wish to do their own processing, or turnkey end-to-end analysis and delivery of results for researchers who prefer to view imaging as a

Public Health Relevance

The importance of biomedical imaging continues to grow, presenting increasing demands for better and faster image post-processing to handle the flood of image data that can be produced from multimodality and serial imaging studies. Continuing development of these techniques by imaging scientists in collaboration with clinicians has been and continues to be a major thrust of the ICAR Facility. Preclinical imaging also continues to grow in importance, and the Facility provides a critical resource for cancer researchers who are not imaging specialists to maximize the scientific value of imaging in their research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA014599-38
Application #
8486640
Study Section
Subcommittee G - Education (NCI)
Project Start
2013-04-01
Project End
2018-03-31
Budget Start
2013-04-23
Budget End
2014-03-31
Support Year
38
Fiscal Year
2013
Total Cost
$78,794
Indirect Cost
Name
University of Chicago
Department
Type
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Trujillo, Jonathan A; Sweis, Randy F; Bao, Riyue et al. (2018) T Cell-Inflamed versus Non-T Cell-Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection. Cancer Immunol Res 6:990-1000
Zeng, Zongyue; Huang, Bo; Huang, Shifeng et al. (2018) The development of a sensitive fluorescent protein-based transcript reporter for high throughput screening of negative modulators of lncRNAs. Genes Dis 5:62-74
Lee, Ji-Hye; Park, Beom Seok; Han, Kang R et al. (2018) Insight Into the Interaction Between RNA Polymerase and VPg for Murine Norovirus Replication. Front Microbiol 9:1466
Cheng, Jason X; Chen, Li; Li, Yuan et al. (2018) RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia. Nat Commun 9:1163
Johnson, Marianna B; Hoffmann, Joscelyn N; You, Hannah M et al. (2018) Psychosocial Stress Exposure Disrupts Mammary Gland Development. J Mammary Gland Biol Neoplasia 23:59-73
Sweis, Randy F; Zha, Yuanyuan; Pass, Lomax et al. (2018) Pseudoprogression manifesting as recurrent ascites with anti-PD-1 immunotherapy in urothelial bladder cancer. J Immunother Cancer 6:24
Kathayat, Rahul S; Cao, Yang; Elvira, Pablo D et al. (2018) Active and dynamic mitochondrial S-depalmitoylation revealed by targeted fluorescent probes. Nat Commun 9:334
Liu, Jun; Eckert, Mark A; Harada, Bryan T et al. (2018) m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer. Nat Cell Biol 20:1074-1083
Bhanvadia, Raj R; VanOpstall, Calvin; Brechka, Hannah et al. (2018) MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease. Clin Cancer Res 24:3668-3680
Wood, Kevin; Byron, Elizabeth; Janisch, Linda et al. (2018) Capecitabine and Celecoxib as a Promising Therapy for Thymic Neoplasms. Am J Clin Oncol 41:963-966

Showing the most recent 10 out of 668 publications